Yttrium-90 Radioembolization for Unresectable, Chemoresistant Breast Cancer Liver Metastases: A Large Single-Center Experience of 40 Patients

[1] Siegel R(2013)Cancer statistics, 2013 CA Cancer J Clin 63 11-30

[2] Naishadham D(2008)Residual risk of breast cancer recurrence 5 years after adjuvant therapy J Natl Cancer Inst 100 1179-1183

[3] Jemal A(1994)The regional treatment of liver metastases from breast cancer J Surg Oncol 55 26-31

[4] Brewster AM(2012)Optimal outcomes for liver-dominant metastatic breast cancer with transarterial chemoembolization with drug-eluting beads loaded with doxorubicin Breast Cancer Res Treat 132 753-763

[5] Hortobagyi GN(2011)Hepatic resection for metastatic breast cancer: a systematic review Eur J Cancer 47 2282-2290

[6] Broglio KR(2006)Hepatic resection for noncolorectal nonendocrine liver metastases: analysis of 1, 452 patients and development of a prognostic model Ann Surg 244 524-535

[7] Schneebaum S(2010)Liver resection for multimodal treatment of breast cancer metastases: identification of prognostic factors Ann Surg Oncol 17 1546-1554

[8] Walker MJ(2010)Factors predicting response and survival after yttrium-90 radioembolization of unresectable neuroendocrine tumor liver metastases: a critical appraisal of 48 cases Ann Surg 251 910-916

[9] Young D(2011)Radioembolization and systemic chemotherapy improves response and survival for unresectable colorectal liver metastases J Cancer Res Clin Oncol 137 865-873

[10] Farrar WB(2013)Yttrium-90 radioembolization for intrahepatic cholangiocarcinoma: safety, response, and survival analysis J Vasc Interv Radiol 24 1227-1234

[1] Siegel R(2013)Cancer statistics, 2013 CA Cancer J Clin 63 11-30

[2] Naishadham D(2008)Residual risk of breast cancer recurrence 5 years after adjuvant therapy J Natl Cancer Inst 100 1179-1183

[3] Jemal A(1994)The regional treatment of liver metastases from breast cancer J Surg Oncol 55 26-31

[4] Brewster AM(2012)Optimal outcomes for liver-dominant metastatic breast cancer with transarterial chemoembolization with drug-eluting beads loaded with doxorubicin Breast Cancer Res Treat 132 753-763

[5] Hortobagyi GN(2011)Hepatic resection for metastatic breast cancer: a systematic review Eur J Cancer 47 2282-2290

[6] Broglio KR(2006)Hepatic resection for noncolorectal nonendocrine liver metastases: analysis of 1, 452 patients and development of a prognostic model Ann Surg 244 524-535

[7] Schneebaum S(2010)Liver resection for multimodal treatment of breast cancer metastases: identification of prognostic factors Ann Surg Oncol 17 1546-1554

[8] Walker MJ(2010)Factors predicting response and survival after yttrium-90 radioembolization of unresectable neuroendocrine tumor liver metastases: a critical appraisal of 48 cases Ann Surg 251 910-916

[9] Young D(2011)Radioembolization and systemic chemotherapy improves response and survival for unresectable colorectal liver metastases J Cancer Res Clin Oncol 137 865-873

[10] Farrar WB(2013)Yttrium-90 radioembolization for intrahepatic cholangiocarcinoma: safety, response, and survival analysis J Vasc Interv Radiol 24 1227-1234